Langham S, Wright A, Kenworthy J, Grieve R, Dunlop WCN. Cost-effectiveness of take-home naloxone for the prevention of overdose fatalities among heroin users in the UK. Value Health 2018;21(4):407–15.

Budget impact analysis of oral glycopyrronium bromide (Sialanar™) for the symptomatic treatment of severe sialorrhoea (drooling) in the UK setting

Langham S, Wright A, Shaw H, Bryson S, O’Leary S. Budget impact analysis of oral glycopyrronium bromide (Sialanar™) for the symptomatic treatment of severe sialorrhoea (drooling) in the UK setting. Value Health 2017;20(9):A720

Cost-effectiveness of take-home naloxone for the prevention of fatalities from heroin overdose in the UK

Langham S, Kenworthy JJ, Grieve R, Dunlop W. Cost-effectiveness of take-home naloxone for the prevention of fatalities from heroin overdose in the UK. Value Health 2016:19(7):A525–6